Beyond Inheritance by Roxanne Khamsi: A Review
An inaugural entry in HD Reads, our ongoing series of reviews of the books shaping how we think about health, longevity, and the science of being human. We begin with Roxanne Khamsi’s Beyond Inheritance, a genuinely important book that may quietly redraw the way you think about your own biology.
Every so often a science book arrives that changes the questions a reader can ask of her own body. The Selfish Gene did it for evolutionary thought in 1976. The Emperor of All Maladies did it for cancer in 2010. Ed Yong’s I Contain Multitudes did it for the microbiome in 2016.
Roxanne Khamsi’s Beyond Inheritance, published this month by Riverhead Books, is the book that does it for somatic mutation, the slow accumulation of DNA changes inside our own cells across a lifetime. The conceptual territory the book opens is so consequential, and so under-represented in public conversation, that we believe it will be remembered as a turning point in the popular literature of biology.
It is also exactly the right book for any reader trying to make sense of where modern medicine is going, why cancer and autoimmunity and aging now look more related than they used to, and what the next decade of clinical research is most likely to deliver. Khamsi has written, with extraordinary clarity and discipline, the foundation text for what we have been calling on this site the Mosaic Body.
The author
Khamsi is among the most accomplished science journalists working today. A contributing writer at The Atlantic, formerly Chief News Editor at Nature Medicine, with bylines spanning The New York Times, The Economist, Wired, Scientific American, and the National Geographic, her career has been built at the intersection of genetics and clinical medicine. She holds a degree in biology from Dartmouth, with a concentration in genetics. She has taught science communication at the Alan Alda Center and the CUNY journalism school. Her reporting has been recognized with top honors from the American Medical Writers Association and the Association of Health Care Journalists.
What that pedigree produces, in Beyond Inheritance, is a writer who understands how scientists think well enough to translate without distorting, and who understands how readers read well enough to keep them with her through some genuinely complex material. The result reads, at its best, like an extended New Yorker profile of an idea, with all the intellectual seriousness and narrative pleasure that implies.
The argument
The thesis of Beyond Inheritance is, in its essentials, simple enough to state in a single sentence. The genome you inherited at conception is not the genome you have now. Nor is it the genome you will have tomorrow.
From there, Khamsi spends roughly three hundred pages explaining what that sentence actually means, and why the implications reach into nearly every corner of human health.
The standard story most of us learned in high school biology was that mutations are either inherited (from your parents, present in every cell, sometimes causing genetic disease) or sporadic and rare (popping up in a single cell, occasionally seeding cancer, otherwise inert). What the last fifteen years of high-precision sequencing has revealed, and what Khamsi documents with a journalist’s discipline and a scientist’s accuracy, is that the second category is far larger and more consequential than anyone had appreciated. Your cells acquire DNA changes constantly. By middle age, your body is a patchwork of cellular populations carrying subtly different genomes. Some of those mutated populations cause disease. Some of them, remarkably, cure it. Most of them do nothing at all.
“You are a slightly different genetic version of yourself today from yesterday,” Khamsi writes in one of the book’s most-quoted lines, “and will be different yet again tomorrow.” It is the kind of sentence that lands quietly, then keeps reverberating.
The book moves through this material in a structure that honors the diversity of fields it has to draw from. There are chapters on cancer as cellular evolution, on clonal hematopoiesis and heart disease, on the somatic mutations now being implicated in autoimmunity, on the strange phenomenon of phenocopy (where an acquired mutation produces the same disease pattern as an inherited one), on the somatic side of neurodegeneration, on the role of mutation in immune memory, and on what may be the book’s most striking thread: the cases where acquired mutations actually heal.
The most surprising chapter
If Beyond Inheritance has a single most important contribution to popular biology, it may be the case it builds for the beneficial side of somatic mutation, an idea most general readers will encounter for the first time in this book.
The reviewers have noticed. Jerome Groopman in The New Yorker called Khamsi’s emphasis on the beneficial aspects of somatic mutations “one of the most striking elements of her book.” Kirkus singled out as “perhaps the most fascinating chapter” the section in which Khamsi documents how acquired mutations have spontaneously rescued children with so-called bubble-boy disease, severe combined immunodeficiency, by happening to disable the broken gene in just the right way. The mutated immune cells outcompeted their broken neighbors, the immune system rebuilt itself, and the children, in effect, cured themselves through internal evolution.
Khamsi reports the same phenomenon in tyrosinemia, where compensating mutations in the liver gradually repopulate the organ with healthier tissue. She traces it through the rare skin disease epidermolysis bullosa, where revertant mutations in patches of skin produce islands of normal-looking tissue in a body otherwise covered in fragile, blistering patches. She makes the case, persuasively, that the same machinery responsible for cancer is also responsible for some of the body’s most extraordinary acts of self-repair, and that the difference between disaster and rescue often comes down to which gene the dice happened to land on.
Featured Partner
Invest in the Infrastructure Behind Modern Medicine
As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.
Learn More →This is a genuinely new framing for most readers. Most of us have been taught to think of mutation as universally bad, an enemy to be policed by tumor suppressor genes and DNA repair machinery, a degradation always to be feared. Khamsi shows that the picture is fundamentally more interesting. Some of the mutations that accumulate inside us are slowly killing us. Some of them, in the right place at the right time, are literally saving our lives. The same biological process produces both outcomes, and the next era of medicine will be defined in part by our ability to tell which is which.
What the book does especially well
Three things stand out to us as a publication that thinks about this territory daily.
First, the writing is genuinely good. Not science-writing-good, which sometimes means clear-but-flat. Actually good, in the way that New Yorker longform is good. The sentences move. The metaphors are chosen carefully and used sparingly. The patient stories are reported with the discipline of a science journalist and the narrative attention of a literary one. Readers who do not normally finish science books are likely to finish this one.
Second, Khamsi is a careful and honest reporter on the limits of what we know. The book never overclaims. When the evidence is preliminary, she says so. When clinical translation is decades away, she says so. When a mouse study has not been replicated in humans, she says so. This is the discipline that built her reputation at Nature Medicine, and it carries through into the book. In a field that often produces tabloid headlines about miracle cures, Khamsi’s restraint is itself a contribution.
Third, and most importantly for a general-audience science book, she manages to integrate work from across half a dozen normally unconnected medical specialties into a single coherent picture. Cancer biology. Cardiology. Hematology. Rheumatology. Neuroscience. Aging research. Each of these fields has been quietly accumulating somatic mutation findings for years, but the findings have rarely been brought into a single frame for ordinary readers. Khamsi brings them in. By the end, the reader sees that the same mechanism (slow clonal expansion of mutated cells) is showing up across cardiology and autoimmunity and cancer and aging, and that the convergence is not coincidental.
What the book could have done better
No book is perfect, and an honest review should say where the seams show.
The most considered criticism we have seen comes from David Shaywitz in The Wall Street Journal, who notes that Khamsi’s portrait of the scientific community is more idealized than the reality. Where she is rigorous and clear-eyed about the competitive struggles among cells inside the body, she is gentler about the comparable competitive struggles among scientists in the field. Researchers in Beyond Inheritance are largely “earnest” and “thoughtful,” collaborating in pursuit of nature’s questions. The actual sociology of biomedical research, with its competition for grants, its priority disputes, its replication crises, and its occasional fraud, gets less attention.
Shaywitz’s point lands. The book is about the science, not about the scientists in their full complexity, and that is a defensible authorial choice; not every book has to do everything. But readers should not come away from Beyond Inheritance with the impression that the field of somatic mutation research is uniformly tidy or that every result quoted will replicate. Some of the most interesting findings in this area, including some that Khamsi reports, are still being argued over.
The other small thing worth saying: Beyond Inheritance is a book about a science. It is not, and does not try to be, a self-help book. Readers looking for a chapter titled “Ten Things You Can Do To Reduce Your Somatic Mutation Burden” will not find one. The book is more interested in changing how you understand your body than in giving you a checklist. We think that is the right call. The translation from this science into specific personal action is something publications like ours are well-suited to take up, and Khamsi has wisely left that work to the next generation of writers and clinicians.
Why this book matters for Healthcare Discovery readers
If you have been following our recent coverage of the Mosaic Body, somatic mutations in autoimmune disease, clonal hematopoiesis and cardiovascular risk, or mosaic aging, then Beyond Inheritance is the single best place to deepen that reading. Khamsi covers the same conceptual territory, with greater depth on the historical and scientific background than any single article can.
The book pairs especially well with the most recent breakthroughs we have been covering. Khamsi finished writing it before the April 2026 Sanger Institute paper on somatic mutations in autoimmune thyroid disease was published, and before the Burraco-Boonekamp framework on mosaic aging hit preprint, but the conceptual scaffolding of Beyond Inheritance makes those new findings immediately legible. Read the book, then read our pieces on the latest news, and the picture is unusually complete.
We also think this is one of those rare popular biology books that physicians should read, alongside their patients. The mosaic mutation framework has not yet penetrated clinical practice nearly to the degree that the underlying evidence warrants. A primary care physician with a working understanding of somatic mosaicism will, in the next decade, be substantially better equipped to think about cardiovascular risk, autoimmunity, and unexplained inflammation than one without it. Khamsi’s book is a gift to that physician.
Practical details
Beyond Inheritance is published by Riverhead Books, an imprint of Penguin Random House. It is available as a hardcover ($30.00), an ebook ($15.99), and an audiobook ($14.95). Hardcover ISBN-13: 9798217281626.
You can pick up a copy at your local independent bookstore, or order it online on Amazon.
The verdict
Buy it. Read it slowly. Lend it to the most curious physician you know.
Beyond Inheritance is the most important popular biology book of 2026 to date, and very likely one of the most important of the decade. It is the foundation text for a way of seeing the body that the rest of medicine is going to spend the next ten years catching up to. Khamsi has done the field a real service in writing it, and she has done readers an even larger one.
Five stars.
Frequently asked questions
What is Beyond Inheritance about?
Beyond Inheritance is a 2026 book by science journalist Roxanne Khamsi that explores how acquired (somatic) mutations, DNA changes that accumulate in our cells throughout life rather than being inherited at conception, shape human health, disease, and aging. The book covers the role of these mutations in cancer, heart disease, autoimmune disorders, neurodegeneration, and even cases where mutations spontaneously cure rare genetic conditions.
Who is Roxanne Khamsi?
Roxanne Khamsi is an award-winning science journalist and contributing writer at The Atlantic. She holds a biology degree from Dartmouth with a genetics concentration, served as Chief News Editor at Nature Medicine for over a decade, and has written for The New York Times, The Economist, Wired, Scientific American, and many other major publications. Beyond Inheritance is her first book.
Is Beyond Inheritance accessible to non-scientists?
Yes. Khamsi writes for a general audience and assumes no prior knowledge of genetics or molecular biology. Reviewers consistently praise her ability to make complex material clear without dumbing it down. Readers who have not previously enjoyed science books are likely to finish this one.
How does this book relate to longevity and healthspan?
Beyond Inheritance is, among other things, a book about why we age and what we might one day do about it. Khamsi explores how the slow accumulation of somatic mutations in different tissues contributes to aging, how this process varies between organs, and how emerging diagnostics and therapies may eventually allow us to detect and intervene in dangerous mutational patterns before they cause clinical disease.
Should physicians read this book?
We think so, particularly primary care physicians, cardiologists, oncologists, rheumatologists, and anyone working in longevity medicine. The mosaic mutation framework has not yet been fully integrated into clinical practice, and a working understanding of it will increasingly be valuable for thinking about cardiovascular risk, autoimmunity, and unexplained inflammation in the coming decade.
Where can I buy Beyond Inheritance?
Beyond Inheritance is available at independent bookstores, libraries, and major online retailers. The hardcover, ebook, and audiobook are all in print as of April 21, 2026. Healthcare Discovery readers who purchase through our affiliate link help support the editorial work on this site.
This review opens HD Reads, an ongoing series at Healthcare Discovery covering the books shaping how we think about health, longevity, and the science of being human. The book under review pairs naturally with our pillar essay on why your cells are quietly mutating, and why it’s rewriting medicine, and our recent pieces on somatic mutations and autoimmune disease, clonal hematopoiesis and cardiovascular risk, and mosaic aging.
Khamsi, R. (2026). Beyond Inheritance: Our Ever-Mutating Cells and a New Understanding of Health. New York: Riverhead Books. ISBN-13: 9798217281626.
